Dayana Michel

2PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 05, 2023
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.

Ignace Vergote, Jose Alejandro Pérez-Fidalgo, Erika Paige Hamilton

|Apr 08, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah

Pageof 1